Article and Video CATEGORIES

Cancer Journey

Search By

MET-Amplified Lung Cancer: A New Target for XALKORI?
Author
GRACE Videos and Articles

Lung cancer patients with high MET amplification appear to do well on Xalkori (crizotinib), a drug that is approved for ALK positive patients.

[powerpress]

Next Previous link

Previous PostNext Post